Correlation analysis of deep learning methods in S-ICD screening.

Authors:
ElRefai M; Abouelasaad M; Wiles BM; Dunn AJ; Coniglio S and 3 more

Journal:
Ann Noninvasive Electrocardiol

Publication Year: 2023

DOI:
10.1111/anec.13056

PMCID:
PMC10335624

PMID:
36920649

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ann Noninvasive Electrocardiol

Abbreviation: Ann Noninvasive Electrocardiol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiac & Cardiovascular Systems

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Early diastolic heart sounds caused by the atrial kick.
Bachour K; Mendez E; Jackson S and 2 more (2024) - Transparency Score: 2/6
Electrocardiographic characteristics of bladder cancer patients receiving preoperative chemotherapy…
Chen ZL; Jia KP; Zheng Y and 6 more (2024) - Transparency Score: 4/6
The impact of visit-to-visit heart rate variability on all-cause mortality in atrial fibrillation.
Zhou X; Yuan Q; Yuan J and 3 more (2024) - Transparency Score: 3/6
A method for noninvasive beat-by-beat visualization of His bundle signals.
Sengottuvel S; Shenbaga Devi S; Sasikala M and 2 more (2023) - Transparency Score: 2/6
An annotated ventricular tachycardia (VT) alarm database: Toward a uniform standard for optimizing …
Pelter MM; Carey MG; Al-Zaiti S and 6 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT Dr. Mohamed ElRefai received unrestricted research grant from Boston Scientific. Benedict Wiles received unrestricted research grant and consultancy fees from Boston Scientific. The work of Anthony J. Dunn is jointly funded by Decision Analysis Services Ltd and EPSRC through the Studentship with Reference EP/R513325/1. Professor John Morgan is a Medical Director at Boston Scientific. Paul Roberts receives consultancy fees from Boston Scientific and Medtronic. Other authors have no conflicts of interests to declare."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025